8/ Sources 1. https://t.co/GVw0L4EKTZ 2. https://t.co/2mb6TSsCXe 3. https://t.co/mZQLAudg5z 4. https://t.co/KO6KqCxdAU 5. https://t.co/gfWVhkRx8N 6. https://t.co/HR5LiXqs1a 7. https://t.co/GYP5fdTfCU 8. https://t.co/lNPeB4ML3b 9. https://t.co/XBQxDypITX 10.
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2019 – Aug 2025Where it's discussed
-
X / Twitter55 posts
-
News27 articles
-
Blogs5 articles
-
YouTube3 videos
AI synopsis
What people are saying
The discussions reflect high engagement and interest through mentions of GLP-1's role in reducing inflammation and improving metabolic conditions, highlighting the article’s influence on current scientific conversations. Words like 'important,' 'clinical value,' and phrases like 'mechanisms to improve results' indicate that the article is seen as highly relevant for advancing medical research and treatment strategies.
Most discussions acknowledge the significance of GLP-1 in metabolic health and its therapeutic potential, with some referencing its roles in inflammation and disease management.
Posts show high interest, with mentions of GLP-1's mechanisms, clinical applications, and implications for treatments, indicating active engagement.
Participants reference specific aspects of the publication, such as inflammation reduction and recent clinical findings, demonstrating thoughtful engagement.
Discussions suggest the article's content is impactful, influencing considerations of GLP-1 in innovative therapies and understanding disease mechanisms.
Abstract in brief
- GLP1, released from gut cells, helps regulate blood sugar by increasing insulin secretion, reducing glucagon, slowing gastric emptying, and decreasing food intake, which aids in nutrient absorption and weight control.
- The review discusses how natural and drug-induced GLP1 actions involve specific cell types and pathways, including their roles in metabolic processes, as well as their impact on conditions like obesity, diabetes, inflammation, and cardiovascular health.
- Advancements in GLP1-based therapies, such as oral drugs and multi-target agonists, are highlighted, along with ongoing challenges and future directions for optimizing these treatments for metabolic diseases.]
Top posts
Most liked on X and BlueskyDoes reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce complications? How might that happen given limited immune cell GLP-1R expression? https://t.co/uIf0moqLE2 https://t.co/ZTdr4RJp1u
The physiological importance of GLP-1 for reduction of inflammation, independent of glucose control and weight loss, is highlighted by demonstration that GLP-1-secreting cells not only respond to nutrients, but also act as inflammation sensors. https://t.co/6XwTwF9tpz https://t.co/NZ4mmTgbfb
For those interested in how and where GLP-1 might control #inflammation, some thoughts here @Cell_Metabolism #diabetes #obesity https://t.co/AAH5cZAX6x
In 2018, the real clinical value of GLP-1R agonists #diabetes #heartdisease was consolidated with multiple highly consistent outcome studies. The importance of understanding mechanisms to improve results remains clear https://t.co/5fX4ZE9Aio
Bariatric surgery greatly improves glycemic control, often within days after surgery, independently of weight loss. This is through the action of incretin hormones GLP-1 and GIP. https://t.co/1E029puV5k @GatlanHealth https://t.co/ioV2PGuVcZ
All mentions
Tirzepatide: A New Solution for Type 2 Diabetes and Obesity
Explore the efficacy and safety of tirzepatide, the first dual GLP-1/GIP receptor co-agonist for type 2 diabetes management. The SURPASS trials showed significant reductions in blood sugar and body weight, making it a…
Ozempic: Evaluating Its Risks and Benefits for Weight Loss
Ozempic was created to treat type 2 diabetes but is now popular on social media as a rapid weight loss solution. This video examines the drug's mechanism of action, potential side effects such as muscle loss, and the…
Investigating Metformin's Impact on Lifespan and Muscle Growth
In this episode of Grantigen Deep Dive, we discuss research findings on Metformin and its potential effect on human lifespan. Notably, Metformin may hinder muscle growth, particularly in older adults undergoing…
RT @bryan_johnson: 8/ Sources 1. https://t.co/GVw0L4EKTZ 2. https://t.co/2mb6TSsCXe 3. https://t.co/mZQLAudg5z 4. https://t.co/KO6KqCxdAU…
RT @bryan_johnson: 8/ Sources 1. https://t.co/GVw0L4EKTZ 2. https://t.co/2mb6TSsCXe 3. https://t.co/mZQLAudg5z 4. https://t.co/KO6KqCxdAU…
RT @robertlufkinmd: The physiological importance of GLP-1 for reduction of inflammation, independent of glucose control and weight loss, is…
RT @robertlufkinmd: The physiological importance of GLP-1 for reduction of inflammation, independent of glucose control and weight loss, is…
RT @robertlufkinmd: The physiological importance of GLP-1 for reduction of inflammation, independent of glucose control and weight loss, is…
RT @robertlufkinmd: The physiological importance of GLP-1 for reduction of inflammation, independent of glucose control and weight loss, is…
RT @robertlufkinmd: The physiological importance of GLP-1 for reduction of inflammation, independent of glucose control and weight loss, is…
The physiological importance of GLP-1 for reduction of inflammation, independent of glucose control and weight loss, is highlighted by demonstration that GLP-1-secreting cells not only respond to nutrients, but also act as inflammation sensors. https://t.co/6XwTwF9tpz https://t.co/NZ4mmTgbfb
Bariatric surgery greatly improves glycemic control, often within days after surgery, independently of weight loss. This is through the action of incretin hormones GLP-1 and GIP. https://t.co/1E029puV5k @GatlanHealth https://t.co/ioV2PGuVcZ
RT @bryan_johnson: 8/ Sources 1. https://t.co/GVw0L4EKTZ 2. https://t.co/2mb6TSsCXe 3. https://t.co/mZQLAudg5z 4. https://t.co/KO6KqCxdAU…
RT @bryan_johnson: 8/ Sources 1. https://t.co/GVw0L4EKTZ 2. https://t.co/2mb6TSsCXe 3. https://t.co/mZQLAudg5z 4. https://t.co/KO6KqCxdAU…
8/ Sources 1. https://t.co/GVw0L4EKTZ 2. https://t.co/2mb6TSsCXe 3. https://t.co/mZQLAudg5z 4. https://t.co/KO6KqCxdAU 5. https://t.co/gfWVhkRx8N 6. https://t.co/HR5LiXqs1a 7. https://t.co/GYP5fdTfCU 8. https://t.co/lNPeB4ML3b 9. https://t.co/XBQxDypITX 10.
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
@KeTerriblesIvan @EstebanMerchan7 Si es que sabe inglés, ahí le dejo para que lea !! Y aprenda a no hacer el ridículo … pendejo https://t.co/7zLA2rieit
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
RT @DanielJDrucker: Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce comp…
Does reduction of #inflammation contribute to the glucose-and #weightloss independent actions of GLP-1RA to reduce complications? How might that happen given limited immune cell GLP-1R expression? https://t.co/uIf0moqLE2 https://t.co/ZTdr4RJp1u
@Mamarchist @captKangol The compound classes you list would be considered small molecules. Semaglutide is actually a modified version of the endogenously produced peptide hormone GLP-1 (so a biologic). Great review on the biology > https://t.co/OlJxb4TQIL https://t.co/ppp829WXQR
RT @DanielJDrucker: For those interested in how and where GLP-1 might control #inflammation, some thoughts here @Cell_Metabolism #diabetes…
For those interested in how and where GLP-1 might control #inflammation, some thoughts here @Cell_Metabolism #diabetes #obesity https://t.co/AAH5cZAX6x
https://t.co/D9oIXjSCHC
RT @DanielJDrucker: In 2018, the real clinical value of GLP-1R agonists #diabetes #heartdisease was consolidated with multiple highly consi…
#Mechanisms of Action and -#Therapeutic Application of Glucagon-like Peptide-1. #GLP1 @CellPressNews https://t.co/ieOATntAFb
In 2018, the real clinical value of GLP-1R agonists #diabetes #heartdisease was consolidated with multiple highly consistent outcome studies. The importance of understanding mechanisms to improve results remains clear https://t.co/5fX4ZE9Aio